GR1001395B - Contraception compositions and methods - Google Patents
Contraception compositions and methodsInfo
- Publication number
- GR1001395B GR1001395B GR900100369A GR900100369A GR1001395B GR 1001395 B GR1001395 B GR 1001395B GR 900100369 A GR900100369 A GR 900100369A GR 900100369 A GR900100369 A GR 900100369A GR 1001395 B GR1001395 B GR 1001395B
- Authority
- GR
- Greece
- Prior art keywords
- contraception
- compositions
- methods
- melatonin
- analog
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 abstract 3
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 abstract 2
- 229960003987 melatonin Drugs 0.000 abstract 2
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000016087 ovulation Effects 0.000 abstract 1
- 239000000583 progesterone congener Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Abstract
Μέθοδος αντισυλλήψεως εις γυναίκα περιλαμβάνει την χορήγησιν μιας ανασταλτικής της ωορρηξίας ποσότητος μελατονίνης ή αναλόγου αυτής. Προαιρετικώς δύναται η μελατονίνη ή το ανάλογον της μελατονίνης να χορηγείται σε συνδυασμό μετά ουσίας εχούσης προεμμηνορροϊκήν ενέργειαν (progestogen) και/ή οιστρογόνου. ωA method of contraception in a female comprises administering an ovulation-inhibiting amount of melatonin or an analog thereof. Optionally, melatonin or the melatonin analog can be administered in combination with a substance having premenstrual action (progestogen) and/or estrogen. oh
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/029,229 US4855305A (en) | 1987-03-23 | 1987-03-23 | Compositions and methods of effecting contraception utilizing melatonin |
US35301989A | 1989-05-17 | 1989-05-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
GR900100369A GR900100369A (en) | 1991-10-10 |
GR1001395B true GR1001395B (en) | 1993-10-29 |
Family
ID=26704706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR900100369A GR1001395B (en) | 1987-03-23 | 1990-05-16 | Contraception compositions and methods |
Country Status (1)
Country | Link |
---|---|
GR (1) | GR1001395B (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4614807A (en) * | 1984-10-04 | 1986-09-30 | Eli Lilly And Company | 6,7-dihalomelatonins |
ZA88498B (en) * | 1987-02-02 | 1989-10-25 | Lilly Co Eli | Alkylmelatonins |
US4855305A (en) * | 1987-03-23 | 1989-08-08 | Applied Medical Research | Compositions and methods of effecting contraception utilizing melatonin |
-
1990
- 1990-05-16 GR GR900100369A patent/GR1001395B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GR900100369A (en) | 1991-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI845065A0 (en) | MAONGSAMMANSATT KOMBINATIONSPREPARAT FOER ORALT BRUK FOER FOERHINDRANDE AV GRAVIDITET. | |
NO951592D0 (en) | Process for the preparation of a transdermal therapeutic system | |
DK550188D0 (en) | ANTI-STAGE AND ANTI-ESTROGEN EFFECTS FOR TREATMENT OF HORMONODE-TENDED TUMORS | |
AU500634B2 (en) | Surgical implant | |
ATE143807T1 (en) | USE OF MELATONIN FOR PREPARING A CONTRACEPTIVE COMPOSITION | |
FI944852A (en) | Apparatus and method for holding a medical instrument | |
MX9101784A (en) | TRANSDERMAL CONTRACEPTIVE FORMULATIONS, METHODS AND DEVICES | |
CA2075060A1 (en) | Novel vehicle gases and their use in medical preparations | |
JPS5287894A (en) | Transplanting surgical tube | |
JPS5212797A (en) | Implant inserted into maxilla | |
DK0868188T3 (en) | Contraception kits for female mammals consisting of a combination of progestogen and estrogen | |
AU508224B2 (en) | 9 21-dihalogeno-11 17 -dihydroxy-6 -fluro-16-methyl-pregna-1,4-diene-3,20-diones | |
DE68919194D1 (en) | Hydrogenated diene copolymer composition and process for its preparation. | |
PT78743B (en) | 1-ALKYL-ANDROSTA-1,4-DIEN-3,17-DIONE METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEREOF | |
AU509186B2 (en) | Surgical implant | |
EP0004765A3 (en) | Corticosteroid anti-inflammatory agents, their use and methods for their preparation | |
GR1001395B (en) | Contraception compositions and methods | |
ATE73136T1 (en) | PROCESS FOR THE PREPARATION OF 6ALPHA, 9ALPHADIFLUORO-11BETA, 17ALPHA-DIHYDROXY-16ALPHA-METHYL4-PREGNEN-3,20-DIONE AND ITS DERIVATIVES. | |
CA2056364A1 (en) | Compositions and methods of effecting contraception | |
AU6306886A (en) | Alkylcarboxamides of pyridylalkylamines, their preparation and their use in human and veterinary medicine | |
IE40885B1 (en) | 4-aryl-1,2,3,4-tetrahydropyrrolo(3,4-b)indoles | |
AU495065B2 (en) | Patellar implant and method | |
JPS51133483A (en) | Culture apparatus utilizing light | |
JPS5219444A (en) | Environment-improving air-conditioning method | |
AU497100B2 (en) | Treatine foot and mouth disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ML | Lapse due to non-payment of fees |